Fmoc-2-Trifluoromethyl-D-Phenylalanine

Online Inquiry

CAT#CP16607
CAS352523-15-0
Synonyms/Alias352523-15-0;Fmoc-D-Phe(2-CF3)-OH;Fmoc-2-Trifluoromethyl-D-Phenylalanine;FMOC-D-2-TRIFLUOROMETHYLPHE;Fmoc-D-2-Trifluoromethylphenylalanine;Fmoc-2-(trifluoromethyl)-D-phenylalanine;(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-(trifluoromethyl)phenyl)propanoicacid;Fmoc-L-phe(2-CF3)-OH;(2R)-2-([(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO)-3-[2-(TRIFLUOROMETHYL)PHENYL]PROPANOICACID;(2R)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-3-[2-(trifluoromethyl)phenyl]propanoicacid;2-(Trifluoromethyl)-D-phenylalanine,N-FMOCprotected;47824_ALDRICH;SCHEMBL1409016;47824_FLUKA;ZINC2386920;1326AE;CF-647;PC8357;AKOS025312285;AB10299;AM83486;FMOCTRIFLUOROMETHYLPHENYLALANINE;FMOC-D-2-TRIFLUOROMETHYL-PHE-OH;AC-16851;AK188035
M.F/FormulaC25H20F3NO4
M.W/Mr.455.43
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 GR 82334 is a spirolactam analog with the structure of [[(S, S) Pro-Leu (spiro-γ-lactam)]9,10, Trp11] Physalaemi ...

Insulin was discovered by Banting and Best in 1921. Soon afterwards manufacturing processes were developed to extract the ins ...

 Orexin A (OXA) and orexin B (OXB) are hypothalamic neuropeptides discovered in 1998, which bind to two G-protein ...

 Corticotropin-releasing factor (CRF) is a 41 amino acid peptide that is an important hormone in the hypothalamic ...

 APC 366 [N-(1-hydroxy-2-naphthoyl)-L-arginyl-L-prolinamide], is a novel selective inhibitor of mast cell tryptas ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.